|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gleeson M, Browning G, Burton Martin J, et
al: Scott-Brown's Otorhinolaryngology. Head and Neck Surgery. 7th
edition. Hodder Arnold, Ltd; London: pp. 2292–2304. 2008
|
|
3
|
Schrijvers M: New prognostic markers to
predict clinical outcome in patients with laryngeal cancer.
Radiother Oncol. 100:22–32. 2011.
|
|
4
|
Hunter KD, Parkinson EK and Harrison PR:
Profiling early head and neck cancer. Nat Rev Cancer. 5:127–135.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dequanter D and Lothaire P: The role of
salvage surgery in organ preservation strategies in advanced head
and neck cancer. B-ENT. 4:77–80. 2008.PubMed/NCBI
|
|
6
|
León X, López M, García J, Viza I, Orús C
and Quer M: Supracricoid laryngectomy as salvage surgery after
failure of radiation therapy. Eur Arch Otorhinolaryngol.
264:809–814. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu M, Wu H, Liu T, et al: Regulation of
the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Cell Res. 19:828–837. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sasaki CT and Jassin B: Cancer of the
pharynx and larynx. Am J Med. 111:S118–S123. 2001. View Article : Google Scholar
|
|
9
|
Manjarrez ME, Ocadiz R, Valle L, et al:
Detection of human papillomavirus and relevant tumor suppressors
and oncoproteins in laryngeal tumors. Clin Cancer Res.
12:6946–6951. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Giefing M, Zemke N, Brauze D, et al: High
resolution ArrayCGH and expression profiling identifies PTPRD and
PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal
squamous cell carcinoma. Genes Chromosomes Cancer. 50:154–166.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Li G, Su ZW, et al: Expression of
astrocyte elevated gene-1 protein and its clinical significance in
laryngeal squamous cell carcinoma. Zhonghua Bing Li Xue Za zhi.
42:111–115. 2013.In Chinese. PubMed/NCBI
|
|
12
|
Szaumkessel M, Richter J, Giefing M, et
al: Pyrosequencing-based DNA methylation profiling of Fanconi
anemia/BRCA pathway genes in laryngeal squamous cell carcinoma. Int
J Oncol. 39:505–514. 2011.PubMed/NCBI
|
|
13
|
Lian M, Fang J, Han D, et al: Microarray
gene expression analysis of tumorigenesis and regional lymph node
metastasis in laryngeal squamous cell carcinoma. PLoS One.
8:e848542013. View Article : Google Scholar
|
|
14
|
Colombo J, Fachel AA, De Freitas Calmon M,
Cury PM, Fukuyama EE, Tajara EH, Cordeiro JA, Verjovski-Almeida S,
Reis EM and Rahal P: Gene expression profiling reveals molecular
marker candidates of laryngeal squamous cell carcinoma. Oncol Rep.
21:649–663. 2009.PubMed/NCBI
|
|
15
|
Berger JA, Hautaniemi S, Järvinen AK,
Edgren H, Mitra SK and Astola J: Optimized LOWESS normalization
parameter selection for DNA microarray data. BMC Bioinformatics.
5:1942004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tilford CA and Siemers NO: Gene set
enrichment analysis. Methods Mol Biol. 563:99–121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hulsegge I, Kommadath A and Smits MA:
Globaltest and GOEAST: two different approaches for gene ontology
analysis. BMC Proc. 3:S102009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar
|
|
19
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shannon P, Markiel A, Ozier O, et al:
Cytoscape: a software environment for integrated models of
biomolecular interaction networks. Genome Res. 13:2498–2504. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McNerney ME, Brown CD, Peterson AL, et al:
The spectrum of somatic mutations in high-risk acute myeloid
leukaemia with-7/del (7q). Br J Haematol. 166:550–556. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Son JW, Jeong KJ, Jean WS, et al:
Genome-wide combination profiling of DNA copy number and
methylation for deciphering biomarkers in non-small cell lung
cancer patients. Cancer Lett. 311:29–37. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Milosevic J, Klinge J, Borg AL, Foukakis
T, Bergh J and Tobin NP: Clinical instability of breast cancer
markers is reflected in long-term in vitro estrogen deprivation
studies. BMC Cancer. 13:4732013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamazaki D, Kurisu S and Takenawa T:
Regulation of cancer cell motility through actin reorganization.
Cancer Sci. 96:379–386. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sahai E: Mechanisms of cancer cell
invasion. Curr Opin Genet Dev. 15:87–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Malumbres M, Pevarello P, Barbacid M and
Bischoff JR: CDK inhibitors in cancer therapy: what is next? Trends
Pharm Sci. 29:16–21. 2008. View Article : Google Scholar
|
|
28
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: a changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Q, Su L, Liu N, Zhang L, Xu W and
Fang H: Cyclin dependent kinase 1 inhibitors: a review of recent
progress. Curr Med Chem. 18:2025–2043. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hansel DE, Dhara S, Huang RC, et al:
CDC2/CDK1 expression in esophageal adenocarcinoma and precursor
lesions serves as a diagnostic and cancer progression marker and
potential novel drug target. Am J Surg Pathol. 29:390–399. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McLean GW, Carragher NO, Avizienyte E,
Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase
in cancer–a new therapeutic opportunity. Nat Rev Cancer. 5:505–515.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Miyazaki T, Kato H, Nakajima M, et al: FAK
overexpression is correlated with tumour invasiveness and lymph
node metastasis in oesophageal squamous cell carcinoma. Br J
Cancer. 89:140–145. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Canel M, Secades P, Rodrigo JP, et al:
Overexpression of focal adhesion kinase in head and neck squamous
cell carcinoma is independent of fak gene copy number. Clin Cancer
Res. 12:3272–3279. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Golubovskaya VM, Gross S, Kaur AS, et al:
Simultaneous inhibition of focal adhesion kinase and SRC enhances
detachment and apoptosis in colon cancer cell lines. Mol Cancer
Res. 1:755–764. 2003.PubMed/NCBI
|
|
35
|
Golubovskaya VM and Cance W: Focal
adhesion kinase and p53 signal transduction pathways in cancer.
Front Biosci (Landmark Ed). 15:901–912. 2010. View Article : Google Scholar
|
|
36
|
Chen LF, Cohen EE and Grandis JR: New
strategies in head and neck cancer: understanding resistance to
epidermal growth factor receptor inhibitors. Clin Cancer Res.
16:2489–2495. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Erjala K, Sundvall M, Junttila TT, et al:
Signaling via ErbB2 and ErbB3 associates with resistance and
epidermal growth factor receptor (EGFR) amplification with
sensitivity to EGFR inhibitor gefitinib in head and neck squamous
cell carcinoma cells. Clin Cancer Res. 12:4103–4111. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Maurizi M, Almadori G, Ferrandina G, et
al: Prognostic significance of epidermal growth factor receptor in
laryngeal squamous cell carcinoma. Br J Cancer. 74:1253–1257. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Erdem M, Erdem S, Sanli O, et al:
Up-regulation of TGM2 with ITGB1 and SDC4 is important in the
development and metastasis of renal cell carcinoma. Urol Oncol.
32:25e13–e20. 2014. View Article : Google Scholar
|
|
40
|
Schober M and Fuchs E: Tumor-initiating
stem cells of squamous cell carcinomas and their control by TGF-β
and integrin/focal adhesion kinase (FAK) signaling. Proc Natl Acad
Sci USA. 108:10544–10549. 2011. View Article : Google Scholar
|
